BillionToOne YC 申请

Summer 2017Public

BillionToOne 在 Summer 2017 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2017
行业: HealthcareDiagnostics
团队规模: 300
状态: Public
已发布: 2016

创始人

Oguzhan AtayFounder
David TsaoFounder/CTO

BillionToOne 做什么

BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.

BillionToOne 的 YC 申请，重建版

Y Combinator 申请

BillionToOne，Summer 2017 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

BillionToOne

Describe what your company does in 50 characters or less.

The genetic testing platform detecting and measuring disease.

What is your company going to make? Please describe your product and what it does or will do.

We have built a DNA molecular counter that improves the resolution of cell-free DNA diagnostics by over a thousand times. Our main product, UNITY Screen, is a non-invasive prenatal test that uniquely assesses fetal risk for recessive conditions and chromosomal abnormalities from maternal blood. We are expanding this technology into liquid biopsy tests for cancer, aiming to transform how oncology care detects and monitors disease.

Where do you live now, and where would the company be based after YC?

We currently live and work in Menlo Park, CA, and would keep the company based there after YC.

Explain your decision regarding location.

We are based in Menlo Park because it provides access to top scientific talent and proximity to leading healthcare and biotech partners, which is critical for developing and refining our complex diagnostics technology.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 BillionToOne 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 BillionToOne 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 BillionToOne 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

BillionToOne 是哪个 YC 批次的？

BillionToOne 是 Y Combinator Summer 2017 批次的成员。

谁创立了 BillionToOne？

BillionToOne 由 Oguzhan Atay, David Tsao 创立。

BillionToOne 做什么？